Reaction equation
[OH:1][CH:2]([CH3:7])[CH2:3][C:4]([O-:6])=[O:5].[OH:8][CH:9]([CH3:13])[C:10]([O-:12])=[O:11].[OH:14][CH2:15][CH2:16][CH2:17][C:18]([O-:20])=[O:19].CC1(C)S[C@@H]2[C@H](NC([C@H](N)C3C=CC=CC=3)=O)C(=O)N2[C@H]1C(O)=O.C1C([C@@H](O)[C@H](NC(C(Cl)Cl)=O)CO)=CC=C([N+]([O-])=O)C=1>>[OH:1][CH:2]([CH3:7])[CH2:3][C:4]([O-:6])=[O:5].[OH:1][CH2:2][CH2:3][C:4]([O-:6])=[O:5].[OH:14][CH2:15][CH2:16][CH2:17][C:18]([O-:20])=[O:19].[C:10]([O-:12])(=[O:11])[CH:9]([CH3:13])[OH:8]Participants
6
Procedure
3 hydroxybutyrate-3-hydroxypropionate-4-hydroxybutyrate-lactate tetrapolymer was prepared according to the method of example 2 except that the collected cells was anaerobically cultured for 3 days in MR medium further containing 2 g/L of 3-hydroxybutyrate (3-HB), 2 g/L of 3 hydroxypropionate (3-HP), 1 g/L of 4-hydroxybutyrate (4-HB) and 100 mg/L of ampicillin instead of MR medium further containing 2 g/L of 4-HB, 100 mg/L of ampicillin and 30 mg/L of chloramphenicol.
Sources & evidence
- ORD record
- ord-97184c5ba1c645cd81eebbfdaffea8fe
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08383379B2
Linked notes
Loading…